29Jul 2023
Value of Adherence to Posttreatment Follow‐Up Guidelines for Head and Neck Squamous Cell Carcinoma

Value of Adherence to Posttreatment Follow‐Up Guidelines for Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSCC) patients' posttreatment follow‐up adherence to guidelines was investigated at an academic medical center. Out of 452 patients, only 23.5% adhered in the first year, and 15.9% maintained adherence for 5 years. First-year adherence was linked to better 5-year overall and disease‐specific survival (HR 0.634 and 0.556, respectively). Among those with recurrence (21.7%), early-stage recurrence wasn't linked to adherence.

  • #ent

Like

Save

Share